Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression

View through CrossRef
Porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques. This hypothesis was tested by using KO piglets challenged with PEDV. Two single-guide RNAs targeting the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertilized eggs; 4 live founders generated and proven to be biallelic KO, lacking detectable N-glycolylneuraminic acid (NGNA). The founders were bred, and homozygous offspring were obtained. Two-day-old (in exps. I and III) and 3-day-old (in exp. II) KO and wild-type (WT) piglets were inoculated with TCID50 1x103 PEDV and then fed 20 mL of infant formula (in exps. I and II) or sow’s colostrum (in exp. III) every 4 hours. In exp. III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution. At 72 hours post-PEDV inoculation (hpi), the animals were euthanized for necropsy, and their intestines were sampled. In all 3 experiments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO. In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi. Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte vacuolization was observed in KO piglets. In exp. II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II. These results suggest that porcine CMAH KO with nullified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.
Title: Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression
Description:
Porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques.
This hypothesis was tested by using KO piglets challenged with PEDV.
Two single-guide RNAs targeting the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertilized eggs; 4 live founders generated and proven to be biallelic KO, lacking detectable N-glycolylneuraminic acid (NGNA).
The founders were bred, and homozygous offspring were obtained.
Two-day-old (in exps.
I and III) and 3-day-old (in exp.
II) KO and wild-type (WT) piglets were inoculated with TCID50 1x103 PEDV and then fed 20 mL of infant formula (in exps.
I and II) or sow’s colostrum (in exp.
III) every 4 hours.
In exp.
III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution.
At 72 hours post-PEDV inoculation (hpi), the animals were euthanized for necropsy, and their intestines were sampled.
In all 3 experiments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO.
In exp.
I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi.
Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte vacuolization was observed in KO piglets.
In exp.
II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little.
In exp.
III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp.
II.
These results suggest that porcine CMAH KO with nullified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.

Related Results

Introduction to CRISPR/Cas9
Introduction to CRISPR/Cas9
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Genome engineering using CRISPR
Genome engineering using CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
ets for CRISPR/Cas9-mediated gene drive in Bemisia tabaci
ets for CRISPR/Cas9-mediated gene drive in Bemisia tabaci
The goal of our BARD proposal was to build both the necessary infrastructure and knowledge for using the CRISPR/Cas9-based gene drive system to control the whitefly Bemisia tabaci....
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Since its inception in 2012, the gene editing technology CRISPR-Cas9 has rapidly become a revolutionary tool in the field of gene editing due to its high efficiency, specificity, a...
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
Background: CRISPR/Cas9 genome-editing technology has revolutionized human stem cell (HSC) research, offering novel therapeutic and diagnostic applications. HSCs play a crucial rol...
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
The revolutionary potential of CRISPR-Cas9 in medicine lies in its unparalleled precision in gene editing, heralding a new era for treating genetic disorders. This study focuses on...
CRISPR/Cas9 genome editing clinical trials for neurodevelopmental disorders
CRISPR/Cas9 genome editing clinical trials for neurodevelopmental disorders
IntroductionRecently, the new therapeutic approach based on genome editing using the CRISPR/Cas9 system has been applied to treat cancer and other monogenetic disorders. CRISPR/Cas...

Back to Top